AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Neuhaus, T Hertfelder, HJ Hess, L Oldenburg, J Walger, P Vetter, H
Citation: T. Neuhaus et al., An uncommon cause of severe bleeding during phenprocoumon treatment, DEUT MED WO, 126(25-26), 2001, pp. 754-756

Authors: Oldenburg, J
Citation: J. Oldenburg, Mutation profiling in haemophilia A, THROMB HAEM, 85(4), 2001, pp. 577-579

Authors: Oldenburg, J Kriz, K Wuillemin, WA Maly, FE von Felten, A Siegemund, A Keeling, DM Baker, P Chu, K Konkle, BA Lammle, B Albert, T
Citation: J. Oldenburg et al., Genetic predisposition to bleeding during oral anticoagulant therapy: Evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10), THROMB HAEM, 85(3), 2001, pp. 454-457

Authors: Bestmann, L Zuger, M Oldenburg, J Buhler, D Maly, FE
Citation: L. Bestmann et al., Coagulation factor IX propeptide mutations causing coumarin hypersensitivity: Identification of female Alanine-10 valine heterozygotes, THROMB HAEM, 85(3), 2001, pp. 567-568

Authors: Oldenburg, J Ivaskevicius, V Rost, S Fregin, A White, K Holinski-Feder, E Muller, CR Weber, BHF
Citation: J. Oldenburg et al., Evaluation of DHPLC in the analysis of hemophilia A, J BIOCH BIO, 47(1-2), 2001, pp. 39-51

Authors: Ivaskevicius, V Jurgutis, R Rost, S Muller, A Schmitt, C Wulff, K Herrmann, FH Muller, CR Schwaab, R Oldenburg, J
Citation: V. Ivaskevicius et al., Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data, BR J HAEM, 112(4), 2001, pp. 1062-1070

Authors: Schneppenheim, R Budde, U Obser, T Brassard, J Mainusch, K Ruggeri, ZM Schneppenheim, S Schwaab, R Oldenburg, J
Citation: R. Schneppenheim et al., Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease, BLOOD, 97(7), 2001, pp. 2059-2066

Authors: Leuer, M Oldenburg, J Lavergne, JM Ludwig, M Fregin, A Eigel, A Ljung, R Goodeve, A Peake, I Olek, K
Citation: M. Leuer et al., Somatic mosaicism in hemophilia A: A fairly common event, AM J HU GEN, 69(1), 2001, pp. 75-87

Authors: Brackmann, HH Effenberger, E Hess, L Schwaab, R Oldenburg, J
Citation: Hh. Brackmann et al., NovoSeven (R) in immune tolerance therapy, BL COAG FIB, 11, 2000, pp. S39-S44

Authors: Oldenburg, J von Brederlow, B Fregin, A Rost, S Wolz, W Eberl, W Eber, S Lenz, E Schwabb, R Brackmann, HH Effenberger, W Harbrecht, U Schurgers, LJ Vermeer, C Muller, CR
Citation: J. Oldenburg et al., Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex, THROMB HAEM, 84(6), 2000, pp. 937-941

Authors: Oldenburg, J Brackmann, HB Hanfland, P Schwaab, R
Citation: J. Oldenburg et al., Molecular genetics in haemophilia A, VOX SANGUIN, 78, 2000, pp. 33-38

Authors: Brackmann, HH Schwaab, R Effenberger, W Hess, L Hanfland, P Oldenburg, J
Citation: Hh. Brackmann et al., Antibodies to factor VIII in hemophilia A patients, VOX SANGUIN, 78, 2000, pp. 187-190

Authors: Schwaab, R Oldenburg, J Kemball-Cook, G Albert, T Juhler, C Hanfland, P Ingerslev, J
Citation: R. Schwaab et al., Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family, BR J HAEM, 109(3), 2000, pp. 523-528

Authors: Oldenburg, J Rost, S El-Maarri, O Leuer, M Olek, K Muller, CR Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2805-2806

Authors: Oldenburg, J Rost, S El-Maarri, O Leuer, M Olek, K Muller, CR Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2905-2906

Authors: Haack, A Schmitt, C Poller, W Oldenburg, J Hanfland, P Brackmann, HH Schwaab, R
Citation: A. Haack et al., Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines, ANN HEMATOL, 78(3), 1999, pp. 111-116

Authors: Lenz, E Repas-Humpe, M Oldenburg, J Kreuz, W Schroter, W Eber, SW
Citation: E. Lenz et al., Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa, EUR J PED, 158(11), 1999, pp. 951-952

Authors: Ehrenreich, H Oldenburg, J Hasselblatt, M Herms, J Dembowski, C Loffler, BM Bruck, W Kamrowski-Kruck, H Gall, S Siren, AL Schilling, L
Citation: H. Ehrenreich et al., Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system, NEUROSCIENC, 91(3), 1999, pp. 1067-1075

Authors: Oldenburg, J Schwaab, R Brackmann, HH
Citation: J. Oldenburg et al., Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome, VOX SANGUIN, 77, 1999, pp. 49-54

Authors: El-Maarri, O Oldenburg, J Caglayan, SH
Citation: O. El-maarri et al., Intron 22-specific long PCR for the Xba I polymorphism in the factor VIII gene, BR J HAEM, 105(4), 1999, pp. 1120-1122

Authors: Ehrenreich, H Loffler, BM Hasselblatt, M Langen, H Oldenburg, J Subkowski, T Schilling, L Siren, AL
Citation: H. Ehrenreich et al., Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors, BIOC BIOP R, 261(1), 1999, pp. 149-155

Authors: Brackmann, HH Effenberger, W Hess, L Schwaab, R Oldenburg, J
Citation: Hh. Brackmann et al., Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?, EUR J HAEMA, 61, 1998, pp. 18-23
Risultati: 1-22 |